Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled risperidone discontinuation trial in people with intellectual disability
2014-003718-10Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of risperidone in behavioral disorder (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Behavior measured by Aberrant Behaviour Checklist irritability subscale. Started Sep 2015; status: completed.
02
Drugs
risperidone
03
Conditions
behavioral disorder
Beyond the preview
Go deeper on 2014-003718-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003718-10.